Financials
- Market Capitalization 12.51 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3 449
売上高対価格比率
5.56
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 803 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.29 USD | -0.49% | -3.35% | +5.19% | +13.47% | 12.64 B USD | ||
| 806 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.69 USD | +0.89% | +3.94% | +0.39% | +28.35% | 12.56 B USD | ||
| 824 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.92 USD | -0.13% | +0.68% | +28.70% | +60.06% | 12.14 B USD | ||
| 852 | SMMT Summit Therapeutics Inc. - Common Stock | 14.33 USD | +0.70% | +12.83% | +13.64% | -27.84% | 11.43 B USD |